VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 185 filers reported holding VIKING THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,002,882 | -33.5% | 632,600 | -2.7% | 1.97% | -46.5% |
| Q2 2023 | $10,536,500 | -11.6% | 650,000 | -9.2% | 3.68% | -6.5% |
| Q1 2023 | $11,923,881 | +111.4% | 716,149 | +19.4% | 3.94% | +77.9% |
| Q4 2022 | $5,640,000 | +729.4% | 600,000 | +140.0% | 2.21% | +1064.2% |
| Q3 2022 | $680,000 | – | 250,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |